These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 9139076

  • 1. Comparison of antibody responses to different forms of HIV-1 core antigens by epitope mapping.
    Truong C, Brand D, Mallet F, Roingeard P, Barin F.
    J Med Virol; 1997 Mar; 51(3):145-51. PubMed ID: 9139076
    [Abstract] [Full Text] [Related]

  • 2. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034
    [Abstract] [Full Text] [Related]

  • 4. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Aug 18; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W, Zou P, Chen YH.
    Immunol Lett; 2004 May 15; 93(2-3):131-6. PubMed ID: 15158608
    [Abstract] [Full Text] [Related]

  • 10. Chimeric synthetic peptides from the nucleocapsid p24 protein of human immunodeficiency virus type-1.
    Hernández M, Rodríguez I, Pozo L, Rivero J.
    Biochem Biophys Res Commun; 2001 Mar 23; 282(1):1-3. PubMed ID: 11263961
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.
    Hochleitner EO, Borchers C, Parker C, Bienstock RJ, Tomer KB.
    Protein Sci; 2000 Mar 23; 9(3):487-96. PubMed ID: 10752610
    [Abstract] [Full Text] [Related]

  • 13. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W.
    Mol Immunol; 2006 Feb 23; 43(5):436-42. PubMed ID: 16337486
    [Abstract] [Full Text] [Related]

  • 14. Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120.
    Luo L, Li Y, Chang JS, Cho SY, Kim TY, Choi MJ, Cheong HS, Kim HJ, Ahn HJ, Min MK, Chun BH, Jung SM, Woo SG, Park SY, Kang CY.
    Virology; 1998 Jan 20; 240(2):316-25. PubMed ID: 9454705
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Affinity capillary electrophoresis investigation of an epitope on human immunodeficiency virus recognized by a monoclonal antibody.
    Qian XH, Tomer KB.
    Electrophoresis; 1998 Mar 20; 19(3):415-9. PubMed ID: 9551794
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection.
    Devadas K, Boykins RA, Hewlett IK, Wood OL, Clouse KA, Yamada KM, Dhawan S.
    Peptides; 2007 Mar 20; 28(3):496-504. PubMed ID: 17188401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.